An Executed Plan to Combat COVID-19 in the United States.

Autor: Hartman WR; Department of Anesthesiology, Office of Clinical Research, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: Wrhartman@wisc.edu.
Jazyk: angličtina
Zdroj: Advances in anesthesia [Adv Anesth] 2022 Dec; Vol. 40 (1), pp. 45-62. Date of Electronic Publication: 2022 Jul 13.
DOI: 10.1016/j.aan.2022.07.002
Abstrakt: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019. To date, this coronavirus is responsible for greater than 90 million cases in the United States and more than 1 million confirmed deaths. When this virus came to the United States, testing was unorganized, no effective treatments were known, and no vaccines had been discovered. A plan to correct these deficiencies through cooperative science and efficient clinical trials was implemented to combat this novel virus. This plan developed efficient and inexpensive tests, highly effective medicines to treat and prevent disease progression, and vaccines to immunize the population.
Competing Interests: Disclosure The author has nothing to disclose.
(Copyright © 2022 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: